First Fiduciary Investment Counsel’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.6M | Buy |
99,224
+386
| +0.4% | +$57.9K | 2.94% | 11 |
|
|
2026
Q1 | $15.1M | Sell |
98,838
-36,610
| -27% | -$5.61M | 3.04% | 12 |
|
|
2025
Q4 | $18.7M | Sell |
135,448
-1,022
| -0.7% | -$134K | 3.62% | 6 |
|
|
2025
Q3 | $17.5M | Sell |
136,470
-353
| -0.3% | -$43.1K | 3.41% | 7 |
|
|
2025
Q2 | $16.6M | Buy |
136,823
+455
| +0.3% | +$51.3K | 3.28% | 7 |
|
|
2025
Q1 | $15.2M | Sell |
136,368
-5,728
| -4% | -$610K | 3.26% | 8 |
|
|
2024
Q4 | $13.8M | Buy |
142,096
+1,645
| +1% | +$175K | 2.81% | 10 |
|
|
2024
Q3 | $16.2M | Sell |
140,451
-1,121
| -0.8% | -$127K | 3.23% | 8 |
|
|
2024
Q2 | $15.1M | Buy |
141,572
+508
| +0.4% | +$51K | 3.27% | 7 |
|
|
2024
Q1 | $13.6M | Sell |
141,064
-2,940
| -2% | -$301K | 2.83% | 11 |
|
|
2023
Q4 | $14.5M | Sell |
144,004
-1,727
| -1% | -$167K | 3.21% | 9 |
|
|
2023
Q3 | $14.8M | Sell |
145,731
-5,140
| -3% | -$522K | 3.48% | 6 |
|
|
2023
Q2 | $15.2M | Sell |
150,871
-3,422
| -2% | -$342K | 3.31% | 10 |
|
|
2023
Q1 | $14.2M | Sell |
154,293
-4,104
| -3% | -$358K | 3.14% | 10 |
|
|
2022
Q4 | $14.4M | Sell |
158,397
-2,382
| -1% | -$201K | 3.15% | 9 |
|
|
2022
Q3 | $12.2M | Sell |
160,779
-886
| -0.5% | -$73.4K | 3.07% | 9 |
|
|
2022
Q2 | $13.7M | Sell |
161,665
-7,706
| -5% | -$676K | 3.09% | 11 |
|
|
2022
Q1 | $14.9M | Sell |
169,371
-852
| -0.5% | -$73.8K | 2.9% | 12 |
|
|
2021
Q4 | $14.9M | Buy |
170,223
+2,845
| +2% | +$236K | 2.64% | 15 |
|
|
2021
Q3 | $13.7M | Sell |
167,378
-1,950
| -1% | -$175K | 2.67% | 16 |
|
|
2021
Q2 | $15.4M | Sell |
169,328
-4,303
| -2% | -$383K | 2.96% | 12 |
|
|
2021
Q1 | $14.8M | Sell |
173,631
-23,062
| -12% | -$2.07M | 2.83% | 14 |
|
|
2020
Q4 | $18.6M | Buy |
196,693
+3,672
| +2% | +$321K | 3.48% | 12 |
|
|
2020
Q3 | $16.8M | Buy |
193,021
+6,081
| +3% | +$527K | 3.49% | 12 |
|
|
2020
Q2 | $16.3M | Sell |
186,940
-693
| -0.4% | -$59.8K | 2.86% | 14 |
|
|
2020
Q1 | $15.5M | Sell |
187,633
-901
| -0.5% | -$80.4K | 4.1% | 9 |
|
|
2019
Q4 | $17.9M | Buy |
188,534
+5,805
| +3% | +$521K | 3.33% | 12 |
|
|
2019
Q3 | $15.9M | Sell |
182,729
-7,435
| -4% | -$668K | 3.36% | 15 |
|
|
2019
Q2 | $17.4M | Sell |
190,164
-60,000
| -24% | -$5.08M | 3.67% | 9 |
|
|
2019
Q1 | $21.6M | Sell |
250,164
-9,285
| -4% | -$745K | 3.99% | 8 |
|
|
2018
Q4 | $19.9M | Buy |
259,449
+3,064
| +1% | +$239K | 4.08% | 9 |
|
|
2018
Q3 | $19.8M | Buy |
256,385
+2,639
| +1% | +$195K | 3.7% | 9 |
|
|
2018
Q2 | $17.2M | Buy |
253,746
+820
| +0.3% | +$56.6K | 3.29% | 11 |
|
|
2018
Q1 | $18.3M | Sell |
252,926
-1,553
| -0.6% | -$118K | 3.64% | 10 |
|
|
2017
Q4 | $19.1M | Sell |
254,479
-5,363
| -2% | -$405K | 3.48% | 11 |
|
|
2017
Q3 | $20M | Sell |
259,842
-14,028
| -5% | -$1.06M | 3.66% | 8 |
|
|
2017
Q2 | $20.5M | Sell |
273,870
-3,945
| -1% | -$280K | 3.92% | 8 |
|
|
2017
Q1 | $18.5M | Buy |
277,815
+6,194
| +2% | +$413K | 3.58% | 13 |
|
|
2016
Q4 | $17.7M | Buy |
271,621
+29,256
| +12% | +$1.9M | 3.39% | 11 |
|
|
2016
Q3 | $17.1M | Buy |
242,365
+79,081
| +48% | +$5.76M | 3.62% | 11 |
|
|
2016
Q2 | $14.4M | Sell |
163,284
-26,332
| -14% | -$1.82M | 3.22% | 13 |
|
|
2016
Q1 | $12.3M | Buy |
189,616
+3,680
| +2% | +$250K | 2.7% | 23 |
|
|
2015
Q4 | $14.3M | Buy |
185,936
+22,510
| +14% | +$1.79M | 3.24% | 13 |
|
|
2015
Q3 | $13.5M | Sell |
163,426
-1,677
| -1% | -$149K | 3.24% | 13 |
|
|
2015
Q2 | $14.5M | Sell |
165,103
-12,946
| -7% | -$1.19M | 3.15% | 13 |
|
|
2015
Q1 | $15.7M | Sell |
178,049
-1,618
| -0.9% | -$144K | 3.39% | 9 |
|
|
2014
Q4 | $14.9M | Buy |
179,667
+9,129
| +5% | +$757K | 3.12% | 14 |
|
|
2014
Q3 | $14.4M | Sell |
170,538
-6,657
| -4% | -$539K | 3.26% | 10 |
|
|
2014
Q2 | $14.4M | Sell |
177,195
-1,410
| -0.8% | -$111K | 3.17% | 10 |
|
|
2014
Q1 | $13.6M | Sell |
178,605
-6,101
| -3% | -$445K | 3.11% | 11 |
|
|
2013
Q4 | $13.3M | Buy |
184,706
+1,561
| +0.9% | +$109K | 3.1% | 10 |
|
|
2013
Q3 | $12.6M | Buy |
183,145
+3,065
| +2% | +$203K | 3.19% | 9 |
|
|
2013
Q2 | $11.4M | Buy |
+180,080
| New | +$11.7M | 2.99% | 15 |
|
Other funds holding NVS
NW
AM
First Fiduciary Investment Counsel's NVS Position: Q2 2026 in Review
First Fiduciary Investment Counsel increased its Novartis (NVS) stake by 0.39% in Q2 2026, buying an estimated $57.9K and bringing the position to 99,224 shares worth $15.6M. The position accounts for 2.94% of the portfolio, ranked #11.
First Fiduciary Investment Counsel first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $21.6M in Q1 2019. 1,109 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- First Fiduciary Investment Counsel held 99,224 shares of Novartis worth $15.6M as of Q2 2026.
- First Fiduciary Investment Counsel bought 386 Novartis shares in Q2 2026, an estimated $57.9K.
- Novartis made up 2.94% of First Fiduciary Investment Counsel's portfolio in Q2 2026, its #11 holding.
- First Fiduciary Investment Counsel first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
- First Fiduciary Investment Counsel's Novartis position peaked at $21.6M in Q1 2019.
- 1,109 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on First Fiduciary Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.